NCT03599258View on ClinicalTrials.gov

Comparison of Phototherapy Using Neolight Skylife Versus Standardized Phototherapy for Hyperbilirubinemia in Newborns

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 15, 2018

Primary Completion Date

January 15, 2020

Study Completion Date

July 15, 2020

Conditions
Jaundice, NeonatalNeonatal HyperbilirubinemiaNeonatal Disorder
Interventions
DEVICE

Skylife

Newly FDA approved device

DEVICE

Standard Therapy

Both devices are considered standard therapy

Trial Locations (2)

85251

HonorHealth Scottsdale Osborn Medical Center, Scottsdale

85260

HonorHealth Scottsdale Shea Medical Center, Scottsdale

Sponsors

Collaborators (1)

Neolight
All Listed Sponsors
collaborator

Neolight

UNKNOWN

lead

HonorHealth Research Institute

OTHER